180 related articles for article (PubMed ID: 31538903)
1. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.
Liu Y; Li Z; Tang X; Li M; Shi F
Recent Pat Anticancer Drug Discov; 2019; 14(3):268-279. PubMed ID: 31538903
[TBL] [Abstract][Full Text] [Related]
2. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
Liu Y; Shi F
Eur J Cancer Prev; 2020 May; 29(3):259-265. PubMed ID: 31651569
[TBL] [Abstract][Full Text] [Related]
3. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
[TBL] [Abstract][Full Text] [Related]
4. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Li JJ; Zheng PCJ; Wang YZ
World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma.
Ge M; Shi M; An C; Yang W; Nie X; Zhang J; Lv Z; Li J; Zhou L; Du Z; Yang M
Sci Rep; 2016 May; 6():26037. PubMed ID: 27185198
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
[TBL] [Abstract][Full Text] [Related]
7. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
Hirokawa T; Arimasu Y; Chiba T; Fujiwara M; Kamma H
Pathol Int; 2020 Apr; 70(4):217-223. PubMed ID: 31943527
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population.
Zhang J; Ju H; Gao JR; Jiao XL; Lu Y
Oncotarget; 2017 Mar; 8(12):20235-20243. PubMed ID: 28423629
[TBL] [Abstract][Full Text] [Related]
11. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
13. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Bu R; Siraj AK; Divya SP; Kong Y; Parvathareddy SK; Al-Rasheed M; Al-Obaisi KAS; Victoria IG; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
Int J Cancer; 2018 May; 142(10):2028-2039. PubMed ID: 29266240
[TBL] [Abstract][Full Text] [Related]
15. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.
Choi JH; Lee J; Yang S; Lee EK; Hwangbo Y; Kim J
Sci Rep; 2018 Oct; 8(1):15004. PubMed ID: 30301923
[TBL] [Abstract][Full Text] [Related]
17. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
18. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
19. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
[TBL] [Abstract][Full Text] [Related]
20. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Huang M; Yan C; Xiao J; Wang T; Ling R
Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
